v3.26.1
Warrants
6 Months Ended
Jun. 30, 2026
Warrants and Rights Note Disclosure [Abstract]  
Warrants

12. Warrants

The following is a schedule of changes in warrants issued and outstanding from December 31, 2025 to June 30, 2026:

 

 

Outstanding as of

 

 

 

 

 

 

 

 

 

 

Outstanding as of

 

 

December 31, 2025

Issued

 

 

Exercised

 

 

Canceled

 

June 30, 2026

 

Registered Direct Offering Warrants

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

2

 

Best Efforts Offering A-1 Warrants

 

 

41

 

 

 

 

 

 

 

 

 

 

 

 

41

 

Best Efforts Offering A-2 Warrants

 

 

41

 

 

 

 

 

 

 

 

 

 

 

 

41

 

Best Efforts Placement Agent Warrants

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

3

 

January 2025 Warrants

 

 

700

 

 

 

 

 

 

 

 

 

 

 

 

700

 

Woodway May 2025 Warrants

 

 

571

 

 

 

 

 

 

 

 

 

 

 

 

571

 

Class A Incremental Notes Warrants

 

 

16,152

 

 

 

20,851

 

 

 

 

 

 

 

 

 

37,003

 

Total Common Stock Purchase Warrants

 

 

17,510

 

 

 

20,851

 

 

 

 

 

 

 

 

 

38,360

 

The warrants are classified as a long-term liability within the condensed consolidated balance sheets and are carried at fair value, with changes in fair value recorded in earnings.

 

Class A Incremental Notes Warrants

In connection with the January 28, 2025 SPA (see Note 11), the Company issued warrants to purchase an aggregate of 20,851 shares of Common Stock during the six months ended June 30, 2026 with initial exercise prices ranging from $48.52 per share to $110.32 per share. The warrants are exercisable for seven years after the issuance date and are subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of common stock.

 

January 2025 and March 2025 Warrants

On January 28, 2025, the Company issued warrants to purchase 963 shares of common stock with an initial exercise price of $7,403.99 per share. The warrants may be exercised during the period commencing January 28, 2025 and ending January 28, 2032. The warrant exercise price is subject to customary adjustments for stock dividends, stock splits, issuances of additional shares of common stock. On

July 7, 2025, the Company entered into an inducement offer letter agreement and agreed to exercise part of the January 2025 Warrants of 263 shares at an exercise price of $379.40 per share.

 

On March 11, 2025, pursuant to the January 2025 SPA, the Company issued warrants to purchase 1,185 shares of Common Stock with an exercise price of $214.20 per share, which expire on March 11, 2032.